The latest news and information about innovations in healthcare.
Hi there ! 😁
Alaedine’s here. I hope that you and your family are safe 💪
➡️ This week has been mainly covid-focused regarding the news. It happens that the coronavirus rases four types of concerns/thoughts :
Detection: it’s all the discussions around testing and tracing.
Treatments: all the scientific papers around drugs like Remdesivir, Hydroxychloroquine, etc.
Vaccine: when and how.
The after: will we come back to a similar before-covid state? Or can we change for the best?
▶️ We triied here to summarize some of the main news. Google just released a publication about the use of a Deep Learning system deployment. Another publication, in Heart Rythm, underlines the importance of wearables in cardiology. The last article shows an algorithm that can (more or less) predict the next disease of a patient based on its EHR.
Wish you great week 🎊,
-Alaedine
What about science?
Each week, we curate some scientific articles that introduce a disrupting innovation or a worth-reading opinion.
With the ongoing development of new features capable of assessing real-time biometric data, the impact of wearables on cardiovascular management has become inevitable.
Early indication and detection of diseases, however, can provide patients and carers with the chance of early intervention, better disease management, and efficient allocation of healthcare resources.
The COVID-19 testing picture in the U.S. is far from easy to understand, given the disparate agencies and public and private health organizations involved.
Despite conflicting studies, results from largest trial yet show the antiviral speeds up recovery, putting it on track to become a standard of care in the United States.
Fiction by Allan Gurganus: “The doctor was soon the only person brave or fool enough to duck under the orange quarantine ropes, ignoring warning signs he himself had nailed to the doors of those farmhouses worst hit.”
The aim is to prepare its psilocybin therapy for phase 3 development. The London-based biotech is advancing the drug, the active ingredient in magic mushrooms, for use in people with treatment-resistant depression.
Dascena’s flagship sepsis algorithm, InSight, has helped reduce the number of deaths by 58 percent and decrease the length of hospital stay by 21 percent, in patients with sepsis.
The ONE Thing: The Surprisingly Simple Truth Behind Extraordinary Results is a non-fiction, self-help book written by authors and real estate entrepreneurs, Gary W. Keller and Jay Papasan.
The book discusses the value of simplifying one’s workload by focusing on the one most important task in any given project.
The book has appeared on the best seller lists of The New York Times, The Wall Street Journal, USA Today, and Amazon.com.
Our mailing address is:
Techstars
1050 Walnut St #202
Boulder, CO 80302
If you were forwarded this newsletter and you like it, you can subscribe here.
If you don’t want these updates anymore, please unsubscribe here.
Manage all your newsletter subscriptions here.
This newsletter is carefully curated with Revue
